• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

peptides

pills oral bottle medicine therapy drug
Biotech

Merck links up with Cyprumed in $493M oral peptide deal

Merck will use Cyprumed’s oral peptide delivery platform for an undisclosed number of targets and up to $493 million biobucks on the table.
Zoey Becker Apr 15, 2025 1:11pm
Illustration connected puzzle pieces with the acronym MA

AbbVie acquires oral peptide biotech Nimble for $200M

Dec 13, 2024 10:38am
dart board miss failure

GemVax's peptide drug fails phase 2a neurodegenerative trial

Oct 29, 2024 11:28am
Photo of Wall Street street sign with american flags in the background

MBX aims for $136M IPO to take rival to Ascendis into phase 3

Sep 9, 2024 11:59am
Graphic image of the letters IPO in white in front of a yellow background

MBX files for IPO to take challenger to Ascendis into phase 3

Aug 26, 2024 9:40am
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

Baker Lab AI makes strides in drug-like peptides

Apr 25, 2024 2:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings